EUVIMEDEUVIMED entdecken
Crossref

Survival after transarterial embolization for spontaneous ruptured hepatocellular carcinoma

Wing-Hong Li, Edmond Cheung-Yan Cheuk, Philip Chong-Hei Kowk, Moon-Tong Cheung

Journal of Hepato-Biliary-Pancreatic Surgery · 2009-07 · 16 (4) · 508-512

DOI: 10.1007/s00534-009-0094-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Surgery, online erschienen am 21.04.2009. Verfasst von Wing-Hong Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Queen Elizabeth Hospital, 31A, Hilary Court, 63G Bonham Road, Hong Kong, Hong Kong. Patvic@netvigator.com. Hauptthemen laut MEDLINE: Embolization, Therapeutic. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To examine the survival of patients with spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization (TAE). METHODS AND MATERIALS: Patients diagnosed with spontaneous ruptured hepatocellular carcinoma treated with TAE were retrospectively studied. Hospital records were reviewed and data were collected and analyzed from the years 2000-2006. A total of 62 patients who had been diagnosed with spontaneous ruptured hepatocellular carcinoma were managed in our hospital during this period. RESULTS: All 62 patients (who had been diagnosed with ruptured hepatocellular carcinoma and were managed in our hospital) patients were treated with TAE, with a success rate of 91% (57/62). Early mortality (within 30 days after rupture) was 38%. Factors that were associated with early mortality were old age, low hemoglobin at presentation, elevated bilirubin at presentation, prolonged prothrombin time at presentation (INR > 1.3), low albumin level at presentation, and unsuccessful embolization. A low albumin level was the only independent risk factor for early mortality. The overall median survival time was 39 days. Surgical resections were possible in seven patients. Their cumulative survival was significantly longer (P = 0.002) than that of patients managed with non-operative treatment after embolization. CONCLUSION: Transarterial embolization (TAE) can achieve good hemostasis, though low albumin level, which reflects poor liver reserve, may predict early mortality. Portal vein thrombosis should not be regarded as an absolute contraindication for TAE. Staged surgical resection after embolization is safe and produces a good survival outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embolization, TherapeuticAdultAgedAged, 80 and overCarcinoma, HepatocellularFemaleHemostasis, SurgicalHospital MortalityHumansLiver NeoplasmsLogistic ModelsMaleMiddle AgedMultivariate AnalysisPortal VeinRetrospective StudiesRupture, SpontaneousVenous Thrombosis

Autor:innen und Institutionen

  • Department of Surgery, Queen Elizabeth Hospital, 31A, Hilary Court, 63G Bonham Road, Hong Kong, Hong Kong. Patvic@netvigator.com

Zitieren

APA

Li, W. H., Cheuk, E. C., Kowk, P. C., & Cheung, M. T. (2009). Survival after transarterial embolization for spontaneous ruptured hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Surgery, 16(4), 508-512. https://doi.org/10.1007/s00534-009-0094-6

Vancouver

Li WH, Cheuk EC, Kowk PC, Cheung MT. Survival after transarterial embolization for spontaneous ruptured hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Surgery. 2009;16(4):508-512. doi:10.1007/s00534-009-0094-6

BibTeX
@article{Li2009,
  author = {Li, Wing-Hong and Cheuk, Edmond Cheung-Yan and Kowk, Philip Chong-Hei and Cheung, Moon-Tong},
  title = {Survival after transarterial embolization for spontaneous ruptured hepatocellular carcinoma},
  journal = {Journal of Hepato-Biliary-Pancreatic Surgery},
  year = {2009},
  volume = {16},
  number = {4},
  pages = {508--512},
  doi = {10.1007/s00534-009-0094-6}
}
Kostenlos starten →